Ajuga iva extract lowers plasma cholesterol and improves lipoprotein profile and lecithin: cholesterol acyltransferase (LCAT) activity in rats fed high cholesterol diet
DOI:
https://doi.org/10.34119/bjhrv7n9-321Keywords:
hypercholesterolemia, Ajuga iva, lipid, lipoproteins, LCAT, ratsAbstract
The purpose of the study was to investigate the therapeutic and preventive effects of Ajuga iva (L) Schreber (Labiatae) (Ai) extract on hypercholesterolemic model rats. For this aim, male Wistar rats were fed a high‑cholesterol (1%) diet to establish a hypercholesterolemia model supplemented or not with aqueous extract of Ajuga Iva (Ai) (5 g/kg diet) for 4 weeks. Ai lowered plasma total cholesterol (TC) (18%) with a reduction in cholesteryl esters (CE) (29%). Low VLDL-TC and high HDL2-TC were observed in Ai group. TC/HDL’s -C ratio was 1.64-fold lower, whereas HDL’s-C/ LDL-HDL1-C was 1.82-fold higher in Ai treated rats. Triacylglycerols (TG) were reduced in plasma and in VLDL but increased in HDL2 and HDL3 with Ai supplementation. Rats exposed to Ai diet lowered VLDL-unesterified cholesterol (UC), LDL-HDL1-amount and LDL-HDL1-CE but increased HDL3-CE. Low levels of liver phospholipids (PL) and high CE concentrations were observed in Ai group. In aorta, TC was decreased by 37% with Ai. Feeding Ai diet decreased HDL3-PL and increased HDL2-CE and plasma LCAT activity. Moreover, Ai administration (5 g/kg for 4 weeks) improved liver and kidney function, as demonstrated by decreased plasma aspartate aminotransferase (AST) activity and creatinine, and resulted in an increase of urinary and sodium excretion. We conclude that, in addition to its Strong C and TG-lowering effect, Ai improves effectively the atherogenic lipoproteins profile by reducing the LDL-HDL1 amount and increasing the HDL-cholesterol. Furthermore, Ai increases the reverse cholesterol transport by enhancement of cholesterol: acyltransferase (LCAT) activity. These beneficial effects are considered potential mechanisms through which Ai acts as a protective agent against cholesterol-induced damage, ensuring cardiovascular safety.
References
Abbasi, B.H.; Ullah, M.A.; Nadeem, M.; Tungmunnithum, D. and Hano, C. (2020). Exogenous application of salicylic acid and gibberellic acid on biomass accumulation, antioxidant and anti-infammatory secondary metabolites production in multiple shoot culture of Ajuga integrifolia Buch. Ham. ex D. Don. Ind Crop Prod. 145, 112098.
Akbay, P.; Gertsch, J.; Calis, I.; Heilmann, J.; Zerbe, O. and Sticher, O. (2001). Novel antileukemic sterol glycosides from Ajuga salicifolia. Helvetica Chim Acta. 85, 1930-1942.
Akinaw, M.A.; Nair, S.K.P.; Usure, R.E.; Leta, B.; Kedir, A.; Mamo, S.A. and et al. (2024). Nephroprotective Effect of the Leaf Extract of Ajuga remota Benth Against Gentamicin-Induced Nephrotoxicity in Swiss Albino Mice. J Exp Pharmacol. 16, 159-171.
Alfarisi, H.A.H.; Ibrahim, M.B., Mohamed, Z.B.H.; Azahari, N. and al. (2020). Hepatoprotective Effects of a Novel Trihoney against Nonalcoholic Fatty Liver Disease: A Comparative Study with Atorvastatin. Sci World J. ID 4503253, 14.
Arafa, H.M.M. (2005). Curcumin attenuates diet-induced hypercholesterolemia in rats. Med Sci Monit. 11, BR228-234.
Badimon, L. and Vilahur, T.P.G. (2012). Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. Eur Heart J Acute Cardiovasc Care. 1, 60-74. doi: 10.1177/2048872612441582.
Bakrima, A.; Ngunjiric, J.; Crouzeta, S.; Guibouta, L.; Balduccid, C. and et al. (2014). Ecdysteroid Profiles of Two Ajuga species, A. iva and A. remota. NPC. 9(8), 1069-1074.
Bennaghmouch, L.; Hajjaji, N.; Zellou, A. and Cherrah, Y. (2001). Pharmacological study of Ajuga iva. Ann Pharm Fr. 59(4), 284.
Beynen, A.C.; Lemmens, A.G.; Katan, M.B.; De Bruijne, J.J. and Van Zutphen, L.F. (1987). Cholesterol metabolism and esterases in four strains of rats with differential cholesterolemic responses to a high-cholesterol, high-cholate diet. Comp Biochem Physiol B. 87(1), 41-8. doi: 10.1016/0305-0491(87)90468-8.
Bondì, M.L.; Al-Hillo, M.R.Y.; Lamara, K.; Ladjel, S.; Bruno, M. and al. (2000). Occurrence of the Antifeedant 14,15-Dihydroajugapitin in the Aerial Parts of Ajuga iva from Algeria. Biochem Syst Ecol. 28, 1023-1025.
Bouderbala, S.; Prost, J. and Bouchenak, M. (2015). Ajuga iva treatment increases post-heparin lipase activity and decreases serum and VLDL-triacyglycerols in rats fed cholesterol-rich diet. Int J Pharm Pharm Sci. 7, 136-140.
Bouderbala, S. and Bouchenak, M. (2020). Effect of Ajuga iva on enzymes involved in the metabolism of cholesterol, in rat fed a cholesterol-enriched diet. Nutr Food Sci. 50, 303-313.
Boudjelal, A.; Siracusa, L.; Henchiri, C.; Sarri, M.; Abderrahim, B. and al. (2015). Antidiabetic Effects of Aqueous Infusions of Artemisia herba-alba and Ajuga iva in Alloxan-Induced Diabetic Rats. Planta Med. 81(9), 696-704.
Burki, S.; Burki, Z.G.; Asghar, M.A.; Ali, I. and Zafar, S. (2021). Phytochemical, acute toxicity and renal protective appraisal of Ajuga parviflora hydromethanolic leaf extract against CCl4 induced renal injury in rats. BMC Complement Med The. 21(1), 198. doi: 10.1186/s12906-021-03360-9.
Burki, S.; Burki, Z.G.; Ahmed, I.; Jahan, N.; Owais, F.; Tahir, N. and Khan, M. (2020). GC/MS assisted phytochemical analysis of Ajuga parviflora leaves extract along with anti-hepatotoxic effect against anti-tubercular drug induced liver toxicity in rat Pak J Pharm Sci. 33, 325–31
Burstein, M.; Scholnick, H.R. and Morfin, R. (1970). Rapid method for isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 11, 583-595.
Burstein, M.H.R.; Fine, A.; Atger, V.; Wirbel, E. and Girard-Globa, A. (1989). Rapid method for isolation of two purified subfractions of high density lipoproteins by differential dextran sulfate-magnesium chloride precipitation. Biochem. 71, 741-746.
Chen, C. and Lacko, A.G. (1986). Determination of endogenous cholesterol esterification by LCAT in plasma. Method in Enzymology. 129, 781-782.
Chenni, A.; Ait Yahia, D.; Boukortt, F.O., Prost, J. and al. (2007). Effect of aqueous extract of Ajuga iva supplementation on plasma lipid profile and tissue antioxidant status in rats fed a high-cholesterol diet. J ethnopharmacol. 109, 207-213.
Chiang, J.Y.L., Ferrell, J.M., Yue Wu, Y. and Boehme, S. (2020). Bile Acid and Cholesterol Metabolism in Atherosclerotic Cardiovascular Disease and Therapy. Cardiol Plus. 5(4), 159-170.
Cicero, A.F.G.; Fogacci, F.; Stoian, A.P.; Vrablik, M., Al Rasadi, K. and al. (2021). Nutraceuticals in the management of dyslipidemia: Which, when, and for whom? Could nutraceuticals help low-risk individuals with non-optimal lipid levels? Curr. Atheroscler Rep. 23(10), 57. doi: 10.1007/s11883-021-00955-y
Coates, P. (2011). Liver function tests. Aust Fam Physician. 40, 113-115.
Council of European Communities. Council instructions about the protection of living animals used in scientific investigations. (1986). Off J Eur Communities (JO 86/609/CEE). L358, 1-28.
Davis, R.A.; Hyde, P.M.; Kuan, J.C.W. and al. (1993). Bile acid secretion by cultured rat hepatocytes. Regulation by cholesterol availability. J Biol Chem. 258, 3661-3667.
Dedić, L.; Banjari, I.; Karuza, J. and Popović, M. (2022). PHYTOSTEROLS AS A MEAN TO ALTER CHOLESTEROL LEVELS. F H D, scientific-professional journal of nutrition and dietetics. 11 (2), 80-91.
Deori, M.; Devi, D.; Kumari, S.; Hazarika, A. ; Kalita, H. and al. (2016). Antioxidant Effect of Sericin in Brain and Peripheral Tissues of Oxidative Stress Induced Hypercholesterolemic Rats. Front Pharmacol. 7, 319. doi: 10.3389/fphar.2016.00319.
Dobiasova, M. and Frohlich, J.J. (1999). Advances in understanding of the role of lecithin cholesterol acyltransferase (LCAT) in cholesterol transport. Clin Chim Acta. 286, 257-271.
Du, Z. and Qin, Y. (2023). Dyslipidemia and Cardiovascular Disease: Current Knowledge, Existing Challenges, and New Opportunities for Management Strategies. J. Clin. Med. 12(1), 363; https://doi.org/10.3390/jcm12010363.
El Hilaly, J. and Lyoussi, B. (2002). Hypoglycemic effect of the lyophilized aqueous extract of Ajuga iva in normal and streptozotocin diabetic rats. J Ethnopharmacol. 80(2-3), 109-13.doi: 10.1016/s0378-8741(01)00407-x.
El-Hilaly, J.; Tahraoui, A.; Israili, Z.H. and Lyoussi, B. (2007). Acute hypoglycemic, hypocholesterolemic and hypotriglyceridemic effects of continuous intravenous infusion of a lyophilised aqueous extract of Ajuga iva L. Schreber whole plant in streptozotocin-induced diabetic rats. Pak J Pharm Sci. 20 (4), 261-268.
El-Tantawy, W.H.; Temraz, A.; Hozaien, H.E.; El-Gindi, O.D. and Taha, K.F. (2015). Anti-hyperlipidemic activity of an extract from roots and rhizomes of Panicum repens L. on high cholesterol diet-induced hyperlipidemia in rats. Z Naturforsch C J Biosci. 70(5-6), 139-44. doi: 10.1515/znc-2014-4147.
Folch, J.; Lees, M and Sloane Stanley, G.H. (1957). A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem. 226, 497-509.
Frederick, J.; Raal, F.J., Rosenson, R.S.; Laurens, F.; Reeskamp, L.F. and al. (2020). Evinacumab for Homozygous Familial Hypercholesterolemia. N Engl J Med. 383(8), 711-720. doi: 10.1056/NEJMoa2004215.
Fujimoto, Y.; Ohyama, K.; Nomura, K.; Hyodo, R., Takahashi, K. et al. (2000). Biosynthesis of sterols and ecdysteroids in Ajuga hairy roots. Lipids. 35, 279-288. doi: 10.1007/s11745-000-0524-z.
Gerald, F.W.; Samuel, S.G.; Pedro, M.; Jing, P.; David, R.S. and al. (2020). Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care. Nat Rev Cardiol. 17(6), 360-377.doi: 10.1038/s41569-019-0325-8.
Hailu, W. and Engidawork, E. (2014). Evaluation of the diuretic activity of the aqueous and 80% methanol extracts of Ajuga remota Benth (Lamiaceae) leaves in mice. BMC Compl. Altern Med. 14(1), 135. doi:10.1186/1472-6882-14-135.
Hamden, K.; Ayadi, F.; Jamoussi, K.; Masmoudi, H. and Elfeki A. (2008). Therapeutic effect of phytoecdysteroids rich extract from Ajuga iva on alloxan induced diabetic rats liver, kidney and pancreas. Biofactors. 33(3): 165-175.
Inomata, Y.; Terahara, N.; Kitajima, J.; Kokubugata, G. and Iwashina, T. (2013). Flavones and anthocyanins from the leaves and flowers of Japanese Ajuga species Lamiaceae. Biochem Syst Ecol. 51, 123–129. doi: 10.1016/j.bse.2013.08.004.
Jeong YJ, Choi YJ, Kwon HM, Kang SW, Parks HS, Lee M and Kang YH. (2005). Differential inhibition of oxidized LDL induced apoptosis in human endothelial cells heated with different flavonoids. Br J Nutr. 93: 581-591.
Kim, E.J.; Kim, B.H.; Seo, H.S.; Lee, Y.J.; Kim, H.H. and al. (2014). Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation. PLoS One. 9(6), e97841 doi: 10.1371/journal.pone.0097841.
Lowry, O.H.; Rosebrough, N.J.; Farr, A.L and Randall, R.J. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem. 193, 256-275.
Mannarino, M.R.; Ministrini, S. and Pirro, M. (2014). Nutraceuticals for the treatment of hypercholesterolemia. Eur J Intern Med. 7, 592-599
Mouheb, S.; Khali, M.; Rouibi, A. and Saidi, F. (2018). Antimicrobial and analgesic activity of aqueaous extract of Algerian Ajuga iva (L.) Schreb (Lamiaceae). Agrobiologia. 8(1), 863-870.
Niimi, M.; Chen, Y.; Yan, H.; Wang, Y.; Koike, T. and Fan, J. (2020). Hyperlipidemic Rabbit Models for Anti-Atherosclerotic Drug Development. Appl Sci. 10, 8681-8699. doi:10.3390/app10238681.
Nijjar, P.S.; Burke, F.M.; Bloesch, A. and Rader, D.J. (2010). Role of dietary supplements in lowering low-density lipoprotein cholesterol: a review. J Clin Lipidol. 4(4), 248-58. doi: 10.1016/j.jacl.2010.07.001
Park, I.W.; Park, K.; Lee, H.S.; Hong, S.M.; Sriramulu, D.K. and al. (2023). Ecdysteroids from the Korean Endemic Species Ajuga spectabilis with Activities against Glucocorticoid Receptors and 11β-Hydroxysteroid Dehydrogenase Type 1 ACS Omega. 138(29), 26191-26200. doi: 10.1021/acsomega.3c02421
Pirillo, A. and Norata, G.D. (2023). The burden of hypercholesterolemia and ischemic heart disease in an ageing world. Pharmacol Res. 193(6), 106814.
Qing, X.; Yan, H.M.; Ni, Z.Y.; Vavricka, C.J.; Zhang, M.L. and al. (2017). Chemical and pharmacological research on the plants from genus Ajuga. Heterocyclic Commu. 23, 245-268. doi: 10.1515/hc-2017-006.
Roger, V.L.; Go, A.S.; Lloyd-Jones, D.M.; Adams, R.J.; Berry, J.D. and al. (2011). Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation. 123(4), e18-e209. doi: 10.1161/CIR.0b013e3182009701.
Saidi, S.; Remok, F.; Handaq, N.; Drioiche, A.; Gourich, A.A. and al. (2023). Phytochemical profile, antioxidant, antimicrobial, and antidiabetic activities of Ajuga iva (L.). Life. 13, 1165. doi:10.3390/life13051165
Samtiya, M.; Aluko, R.E.; Dhewa, T. and Moreno-Rojas, J.M. (2021). Potential Health Benefits of Plant Food-Derived Bioactive Components: An Overview. Foods. 10(4), 839. doi: 10.3390/foods10040839
Schmidt, A.F.; Joshi, R.; Gordillo-Marañón, M.; Drenos, F.; Charoen, P. et al. (2023). Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes. Commun Med. 3(1), 9. doi: 10.1038/s43856-022-00234-0.
Syrov, V.N.; Nasyrova, S.S and Khushbaktova, Z.A. (1997). The results of experimental study of phytoecdysteroids as erythropoiesis stimulators in laboratory animals. Eksperimentalnaia i Klinicheskaia. Farmakologiia. 60, 41-44.
Toiu, A.; Vlase, L.; Gheldiu, A.M.; Vodnar, D. and Oniga, I. (2017). Evaluation of the antioxidant and antibacterial potential of bioactive compounds from Ajuga reptans extracts. Farmacia. 65(3), 351-355.
Vitali, C. and Cuchel, M. (2021). The controversial role of LCAT in the development of atherosclerosis: new insights from an LCAT activator. Arterioscler Thromb Vasc Biol. 41(1), 377-379. doi: 10.1161/ATVBAHA.120.315496
Vos, T.; Lim, S.S. and Abbafati, C. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 396, 1204-1222.
Xu, Y.; Lu, J.; Guo, Y. ; Zhang, Y.; Liu, J.; Huang, S.; Zhang, Y. et al. (2022). Hypercholesterolemia reduces the expression and function of hepatic drug metabolizing enzymes and transporters in rats. Toxicol Lett. 364, 1-11. doi: 10.1016/j.toxlet.2022.05.009.
Yanai, H. (2020). Hyperlipidemia due to Nephrotic Syndrome: Its Effects and Effects of Interventions on Atherogenesis, Cardiovascular and Renal Outcomes. J Endocrinol Metab. 10(3-4), 63-73.
